Research Article

Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma

Table 4

Correlation between the expression of miRNA and different clinical characteristics.

Characteristicslet-7c-5plet-7d-5pmiR-140-3pmiR-185-5pmiR-425-5p
rrrrr

Hemoglobin0.1070.4690.2220.1290.3060.0340.3250.0270.2790.058
Neutrophil0.0380.8020.0200.892−0.0770.6090.0440.7730.0000.998
Platelet0.1150.4400.1060.4770.2560.0830.2590.0860.2960.046
Creatinine−0.3090.033−0.2270.120−0.5270.000−0.5000.000−0.5240.000
Ca−0.1400.341−0.0760.6080.0340.821−0.0130.9300.0760.609
β2-Microglobulin−0.3110.031−0.4120.004−0.4370.002−0.4830.001−0.4530.001
ALP−0.0970.513−0.0880.5510.0960.5150.0780.6060.0440.771
LDH−0.0320.8280.0170.907−0.2010.172−0.1400.354−0.1970.185
VEGF−0.0010.996−0.1470.377−0.1060.526−0.1520.370−0.1050.529
IL-6−0.4260.009−0.2440.146−0.3930.016−0.4200.011−0.5180.001
IL-6R−0.2060.215−0.0910.585−0.0380.823−0.0260.877−0.0960.568
TRAP5B−0.0700.6810.0750.661−0.0570.7380.0380.8280.0220.897
β-CTX−0.3260.047−0.3340.044−0.3460.036−0.3490.037−0.4150.011
25-OH-VD0.1240.4650.1280.4500.1770.2960.2480.1440.2370.158
BAP0.0100.9540.0750.660−0.0580.7310.0580.7370.0900.596
BM PC (%)−0.3110.031−0.4120.004−0.4370.002−0.4830.001−0.4530.001

; ; r, correlation; IL-6, interleukin-6; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; VEGF, vascular endothelial growth factor; IL-6R, interleukin-6 receptor; TRAP5B, tartrate-resistant acid phosphatase; β-CTX, Β-type I collagen carboxy-terminal peptide; 25-OH-VD, 25-hydroxyvitamin D; BAP, bone alkaline phosphatase; BM PC, bone marrow plasma cells.